Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)

BACKGROUND: Patients with ankylosing spondylitis (AS) are at increased risk of depression. This increased risk has been hypothesized to be solely secondary due to AS-related symptoms, or additionally due to a common inflammatory pathway. From a clinical perspective, it is important to know whether t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Arthritis Res Ther
Autori principali: Webers, Casper, Stolwijk, Carmen, Schiepers, Olga, Schoonbrood, Thea, van Tubergen, Astrid, Landewé, Robert, van der Heijde, Désirée, Boonen, Annelies
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523309/
https://ncbi.nlm.nih.gov/pubmed/32993799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-02305-w
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi